Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey
Medical Sciences · 2025
DOI: 10.3390/medsci13030117 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Medical Sciences, 2025. Verfasst von George Gourzoulidis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Health Through Evidence, 17456 Athens, Greece. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Cost of Illness, Health Services Needs and Demand. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Society of Crohn’s Disease and Ulcerative Colitis Patients (HELLESCC).
Abstract (Originalsprache)
Background
Ulcerative colitis (UC) requires life-long disease management. This study aimed to investigate the disease burden and unmet medical needs in UC patients in Greece.
Methods
Between October 2023 and January 2024, adult UC patients who were members of the Hellenic Society of Crohn’s Disease and Ulcerative Colitis Patients (HELLESCC) completed a structured self-reported questionnaire. The survey questionnaire included sociodemographic characteristics, smoking habits, history of comorbidities, disease activity, disease characteristics, medications, and patient-reported outcomes (PROs; Short Inflammatory Bowel Disease Questionnaire [SIBDQ], Work Productivity and Activity Impairment [WPAI], Patient Health Questionnaire-9 [PHQ-9], treatment satisfaction, and treatment adherence). Univariate and multivariate logistic regression analyses were used to identify associated factors.
Results
Datasets were obtained from 181 UC patients, of whom 48% were on advanced therapies (biological/small-molecule agents) and 54% had active disease. Around 74% reported impaired quality of life (QoL) (SIBDQ < 60), 25% work productivity loss, and 29% daily activity impairment. About 40% reported moderate to severe depressive symptoms (PHQ-9 ≥ 10). Reduced adherence and treatment dissatisfaction were reported by approximately one-third of patients. Female gender and disease activity were associated with moderately to severely impaired QoL, work productivity, and mental health. Interestingly, three out of four patients receiving advanced therapy reported moderately to severely impaired QoL and had increased odds of experiencing moderate to severe depression.
Conclusions
The disease burden remains very high in UC, characterized by poor QoL and increased work impairment, depression, and disease activity among Greek patients. Marked treatment dissatisfaction and non-adherence were observed in approximately one-third of patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Through Evidence, 17456 Athens, Greece.
- Hellenic Society of Crohn's Disease's and Ulcerative Colitis' Patients (HELLESCC), 11252 Athens, Greece.
- Department of Accounting and Finance, School of Management, University of Peloponnese, 24100 Kalamata, Greece.
ORCID-Profile: George Gourzoulidis, Vasiliki-Rafaela Vakouftsi, George Mavridoglou
Förderung
- Hellenic Society of Crohn’s Disease and Ulcerative Colitis Patients (HELLESCC)
Zitieren
APA
Gourzoulidis, G., Vakouftsi, V. R., Mavridoglou, G., Psarra, M., & Tzanetakos, C. (2025). Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey. Medical Sciences. https://doi.org/10.3390/medsci13030117
Vancouver
Gourzoulidis G, Vakouftsi VR, Mavridoglou G, Psarra M, Tzanetakos C. Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey. Medical Sciences. 2025. doi:10.3390/medsci13030117
BibTeX
@article{Gourzoulidis2025,
author = {Gourzoulidis, George and Vakouftsi, Vasiliki-Rafaela and Mavridoglou, George and Psarra, Marina and Tzanetakos, Charalampos},
title = {Disease Burden and Unmet Medical Needs in Patients with Ulcerative Colitis in Greece: A Cross-Sectional Patient Survey},
journal = {Medical Sciences},
year = {2025},
doi = {10.3390/medsci13030117}
}
EUVIMED